Dominari Holdings (FRA:BP2A) EV-to-EBIT : -0.43 (As of Jun. 05, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Dominari Holdings EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Dominari Holdings's Enterprise Value is €8.28 Mil. Dominari Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-19.17 Mil. Therefore, Dominari Holdings's EV-to-EBIT for today is -0.43.

The historical rank and industry rank for Dominari Holdings's EV-to-EBIT or its related term are showing as below:

FRA:BP2A' s EV-to-EBIT Range Over the Past 10 Years
Min: -8.32 Med: -0.42 Max: 2.69
Current: -0.43

During the past 13 years, the highest EV-to-EBIT of Dominari Holdings was 2.69. The lowest was -8.32. And the median was -0.42.

FRA:BP2A's EV-to-EBIT is ranked worse than
100% of 425 companies
in the Biotechnology industry
Industry Median: 9.61 vs FRA:BP2A: -0.43

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Dominari Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was €10.10 Mil. Dominari Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was €-19.17 Mil. Dominari Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -189.81%.

Dominari Holdings EV-to-EBIT Historical Data

The historical data trend for Dominari Holdings's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dominari Holdings EV-to-EBIT Chart

Dominari Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-0.94

-0.46

2.82

1.75

-0.11

Dominari Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															1.29	0.25	0.25	-0.11	-0.52

Competitive Comparison of Dominari Holdings's EV-to-EBIT

For the Biotechnology subindustry, Dominari Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dominari Holdings's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Dominari Holdings's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Dominari Holdings's EV-to-EBIT falls into.

Dominari Holdings EV-to-EBIT Calculation

Dominari Holdings's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	8.280	/	-19.168
	=	-0.43

Dominari Holdings's current Enterprise Value is €8.28 Mil.
Dominari Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-19.17 Mil.

Dominari Holdings (FRA:BP2A) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Dominari Holdings's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-19.168	/	10.0986176
	=	-189.81 %

Dominari Holdings's Enterprise Value for the quarter that ended in Mar. 2024 was €10.10 Mil.
Dominari Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-19.17 Mil.

Dominari Holdings EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Dominari Holdings's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Dominari Holdings (FRA:BP2A) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Dominari Holdings Inc (FRA:BP2A) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

DOMH:USA BP2A:Germany

Address

One Rockefeller Plaza, 11th Floor, New York, NY, USA, 10020

Website

https://www.dominariholdings.com

Dominari Holdings Inc is a biotechnology company with a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The company is engaged in developing a therapeutic drug pipeline through partnerships with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore, and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company is also developing an antiviral platform, in which the compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19.

Dominari Holdings (FRA:BP2A) Headlines

No Headlines